NUFEXULT
DEAD

Serial Number

87890385

Owner

H. Lundbeck A/S

Attorney

Maren C. Perry

Filing Date

Apr 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

NUFEXULT Trademark

Serial Number: 87890385 • Registration: 5784963

NUFEXULT is a trademark filed by H. Lundbeck A/S on April 24, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

April 24, 2018

Registration Date

June 25, 2019

Published for Opposition

April 9, 2019

Cancellation Date

January 9, 2026

Goods & Services

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 9, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 25, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 22, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 22, 2024 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 22, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2019 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 6, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 28, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 28, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 28, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 28, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 27, 2019 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 29, 2019 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 15, 2019 CNSA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 9, 2018 GNRN
NON-FINAL ACTION E-MAILED
Nov 9, 2018 GNRT
NON-FINAL ACTION WRITTEN
Nov 9, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 22, 2018 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 28, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 28, 2018 GNSL
SUSPENSION LETTER WRITTEN
Sep 28, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2018 CRFA
ASSIGNED TO LIE
Sep 6, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 26, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2018 NWOS
NEW APPLICATION ENTERED
Apr 27, 2018 NWAP